In short
- Data from 386 healthy volunteers in 15 controlled studies of LSD, psilocybin, mescaline and DMT were pooled.
- Feelings of mystical oneness went most closely with a sense of renewal and of luminous light, and more moderately with the dissolving of the ego.
- Distress also rose with dose, but it was not what linked to oneness.
What the researchers did
Researchers from Basel and Johns Hopkins analysed 816 sets of answers to the Psychedelic Experience Scale (PES100), a detailed questionnaire about what people feel during a session. They looked at how mystical oneness relates to three features described in many religious traditions: renewal (feeling reborn), luminous light and the dissolving of the ego.
What they found
Mystical oneness was most strongly associated with renewal and luminous light, and moderately with ego disintegration. All of these increased with dose. Distress increased with dose too and was strongly tied to ego disintegration, but once the other features were taken into account, distress was no longer linked with oneness.
In other words, the dark and the light sides of a strong experience often travel together, but they are not the same thing.
Why it matters
Light and rebirth run through mystical writing across cultures, from the Christian mystics to Shipibo accounts of the visionary world, and it is striking to see them emerge from questionnaires in a laboratory. There is also a practical message for anyone preparing for a ceremony: losing one’s usual sense of self can feel frightening, and that fear can sit right next to the experience of oneness. Preparation helps people recognise this and not fight it.
Keep in mind
The analysis was not preregistered and used healthy volunteers in controlled settings, mostly in Switzerland and the USA. Correlations do not show what causes what.
Experience it for yourself
Our small-group retreats combine careful preparation, ceremonies and integration, led by psychologists and psychotherapists.
See our retreatsThis summary is for information only and is not medical advice. Psychedelics are controlled substances in many countries, including the UK.
You may also like
Mystical, Not Challenging, Experiences Linked to OCD Improvement
In a Yale trial of psilocybin for treatment-resistant OCD, stronger mystical experiences predicted lower symptoms one and 12 weeks later.
Monika Knitter · 18 September 2026
ResearchCan Esketamine Bring On Mystical Experiences?
In routine depression care, 58% of patients treated with esketamine nasal spray had a mystical-type experience, and these seemed to matter for recovery.
Dr Christoph Zwolan · 17 April 2026
ResearchA Wider Stage: How Psychedelics Reorganise the Workspace of Consciousness
Brain scans suggest LSD, psilocybin and mescaline add more information-gathering hubs to the brain’s global workspace, the stage on which consciousness plays out.
Dr Christoph Zwolan · 13 November 2026
